Abstract
Protein kinase C (PKC) is a family of at least 11 isozymes and known to play a crucial role in myocardial growth. The present study was performed to investigate whether PKC-isozymes are differentially regulated during the development of volume-overload cardiac hypertrophy. After 2, 7 and 30 days of sham or aortocaval shunt operation in male Wistar rats, PKC-activity and the expression of cardiac PKC-isozymes (PKC-α, δ and ε) were determined at the protein and at the mRNA-level in the left and the right ventricle separately. Myocardial hypertrophy after 2, 7 and 30 days of aortocaval shunt was more pronounced in the right than in the left ventricle. Right ventricular hypertrophy was associated with an increased PKC-enzyme activity, a selectively enhanced protein expression of cytosolic PKC-δ (day 7:+83 ± 12%, day 30:+94 ± 14%) and PKC-α (day 7:+48 ± 11%, day 30:+62 ± 16%) and a transcriptional upregulation of the absolute mRNA-levels of these PKC-isozymes in the aortocaval shunt group as compared to controls. In contrast, the expression of PKC-ε was unchanged. A significant upregulation of PKC-δ both on the protein and on the mRNA-level was also noted in volume-overload induced left ventricular hypertrophy, whereas the expression of PKC-α and PKC-ε were not altered. Furthermore, the expression of calcineurin in both ventricles was not significantly changed in response to volume-overload. This study characterizes in the left and right ventricle a differential regulation of the dominant PKC-isozymes in volume-overload cardiac hypertrophy both at the protein and at the mRNA-level. (Mol Cell Biochem 262: 135–143, 2004)
Similar content being viewed by others
References
Parker TG: Molecular biology of cardiac growth and hypertrophy. Herz 18: 245–255, 1993
Sugden PH: Signaling pathways in cardiac myocyte hypertrophy. Ann Med 33: 611–622, 2001
Modesti PA, Vanni S, Bertolozzi I, Cecioni I, Polidori G, Paniccia R, Bandinelli B, Perna A, Liguori P, Boddi M, Galanti G, Serneri GG: Early sequence of cardiac adaptations and growth factor formation in pressure-and volume-overload hypertrophy. Am J Physiol Heart Circ Physiol 279: H976–H985, 2000
Yamakawa H, Imamura T, Matsuo T, Onitsuka H, Tsumori Y, Kato J, Kitamura K, Koiwaya Y, Eto T: Diastolic wall stress and ANG II in cardiac hypertrophy and gene expression induced by volume overload. Am J Physiol Heart Circ Physiol 279: H2939–H2946, 2000
Braun M, LaRosee, Schön, S, Borst MM, Strasser RH: Differential regulation of cardiac protein kinase C isozyme expression after aortic banding. Cardiovas Res 56: 56–63, 2002
Moltkentin JD, Dorn II GW 2nd: Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 63: 391–426, 2001
Wollert KC, Heineke J, Westermann J, Ludde M, Fiedler B, Zierhut W, Laurent D, Bauer MK, Schulze-Osthoff K, Drexler H: The cardiac Fas (APO-1/CD95) Receptor/Fas ligand system: Relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes. Circulation 101: 1172–1178, 2000
Puceat M, Hilal Dandan R, Strulovici B, Brunton LL, Brown JH: Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes. J Biol Chem 269: 16938–16944, 1994
Lavandero S, Cartagena G, Guarda E, Corbalan R, Godoy I, Sapag-<del> </del>Hagar M, Jalil JE: Changes in cyclic AMP dependent protein kinase and active stiffness in the rat volume overload model of heart hypertrophy. Cardiovasc Res 27: 1634–1638, 1993
Garcia R, Diebold S: Simple, rapid, and effective method of producing aortocaval shunts in the rat. Cardiovasc Res 24: 430–432, 1990
Strasser RH, Simonis G, Sch<del>ö</del>ön S, Braun MU, Ihl-Vahl R, Weinbrenner C, KüblerW, Marquetant R: Two distinct mechanisms mediate a differential regulation of protein kinase C isozymes in acute and prolonged myocardial ischemia. Circ Res 85: 77–87, 1999
Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294–5299, 1979
Kraft AS, Anderson WB: Phorbol ester increase the amount of Ca, phospholipid-dependent protein kinase associated with plasma membrane. Nature 301: 621–623, 1983
Huang XP, Pi Y, Lokuta AJ, Greaser ML, Walker JW: Arachidonic acid stimulates protein kinase C-epsilon redistribution in heart cells. J Cell Sci 110: 1625–1634, 1997
Takeuchi K, Nakamura N, Cook NS, Pratt RE, Dzau VJ: Angiotensin II can regulate gene expression by the AP-1 binding sequence via a protein kinase C-dependent pathway. Biochem Biophys Res Commun 172: 1189–1194, 1990
Yamazaki T, Yazaki Y: Molecular basis of cardiac hypertrophy. Z Kardiol 89: 1–6, 2000
Decock JB, Gillespie-Brown J, Parker P, Sugden PH, Fuller SJ: Classical, novel and atypical isoforms of PKC stimulate ANF-and TRE/AP-1-regulated promotor activity in ventricular cardiomyocytes. FEBS Lett 356: 275–278, 1994
Page K, Li J, Corbit KC, Rumilla KM, Soh JW, Weinstein IB, Albanese C, Pestell RG, Rosner MR, Marc Hershenson MB: Regulation of airway muscle cyclin D1 transcription by protein kinase C-d. Am J Respir Cell Mol Biol 27: 204–213, 2002
Shoh JW, Lee EH, Prywes R, Weinstein IB: Novel roles of specific Isoforms of Protein kinase C in activation of the c-fos Serum response element. Mol Cell Biol 34: 1313–1324, 1999
Gu X, Bishop SP: Increased protein kinase C and isozyme redistribution in pressure-overload cardiac hypertrophy in the rat. Circ Res 75: 926–<del> </del>931, 1994
Mende U, Kagen A, Cohen A, Aramburu J, Schoen FJ, Neer EJ: Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci USA 95: 13893–13898, 1998
Braz JC, Bueno OF, De Windt LJ, Molkentin JD: PKC alpha regulates the hypertrohic growth of cardiomyocytes through extracellular signalregulated kinase 1/2 (ERK 1/2). J Cell Biol 156: 905–919, 2002
Takeishi Y, Ping P, Bolli R, Kirkpatrick DL, Hoit BD, Walsh RA: Transgenic overexpression of constitutively active protein kinase C e causes concentric cardiac hypertrophy. Circ Res 86: 1218–1223, 2000
Johnson JA, Gray MO, Chen CH, Mochly-Rosen D: A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem 271: 24962–24966, 1996
Ruzicka M, Leenen FH: Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume-overload induced cardiac hypertrophy. Circulation 91: 16–19, 1995
De Windt LJ, Lim HW, Haq S, Force T, Molkentin JD: Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertophic signaling pathways. J Biol Chem 275: 13571–13579, 2000
Zou Y, Yao A, Zhu W, Kudoh S, Hiroi Y, Shimoyama M, Uozumi H, Kohmoto O, Takahashi T, Shibasaki F, Nagai R, Yazaki Y, Komuro I: Isoproterenol activates extracellular signal-regulated protein kinases in cardimyocytes through calcineurin. Circulation 104: 102–108, 2001
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Braun, M.U., LaRosée, P., Simonis, G. et al. Regulation of protein kinase C isozymes in volume overload cardiac hypertrophy. Mol Cell Biochem 262, 135–143 (2004). https://doi.org/10.1023/B:MCBI.0000038229.23132.9f
Issue Date:
DOI: https://doi.org/10.1023/B:MCBI.0000038229.23132.9f